Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China · Delayed Price · Currency is CNY 24.35
-0.85 (-3.37%)
Sep 10, 2026, 12:44 PM CST
SHE:002940 Revenue
Zhejiang AngLiKang Pharmaceutical CO.,LTD. had revenue of 286.88M CNY in the quarter ending June 30, 2026, a decrease of -24.27%. This brings the company's revenue in the last twelve months to 1.33B, down -6.17% year-over-year. In the year 2025, Zhejiang AngLiKang Pharmaceutical CO.,LTD. had annual revenue of 1.42B, down -7.35%.
Revenue (ttm)
1.33B
Revenue Growth
-6.17%
P/S Ratio
3.72
Revenue / Employee
1.07M
Employees
1,236
Market Cap
4.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.42B | -113.07M | -7.35% |
| Dec 31, 2024 | 1.54B | -82.69M | -5.10% |
| Dec 31, 2023 | 1.62B | 52.13M | 3.32% |
| Jan 1, 2023 | 1.57B | 188.06M | 13.62% |
| Jan 1, 2022 | 1.38B | 90.73M | 7.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Luoxin Pharmaceuticals Group Stock | 2.34B |
| Hunan Fangsheng Pharmaceutical | 1.87B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.56B |
| Beijing Beilu Pharmaceutical | 1.29B |
| Hunan Hansen Pharmaceutical | 1.01B |
| Jiangsu Jibeier Pharmaceutical | 1.00B |
| ChengDu ShengNuo Biotec | 911.15M |
| Teyi Pharmaceutical Group Co.,Ltd | 826.71M |